National Health (Weighted average disclosed price - interim supplementary disclosure cycle) Amendment Determination 2012 (No. 2) (No. PB 98 of 2012)
- F2012L02147
Repealed/Ceased
PB 98 of 2012 Determinations/Health as made
This determination amends the National Health (Weighted average disclosed price - interim supplementary disclosure cycle) Determination 2012 (No. PB 58 of 2012) to determine amended weighted average disclosed prices (WADPs) for brands of pharmaceutical items in the interim supplementary disclosure cycle with the drug docetaxel and an injection manner of administration (MoA) and the drug risedronic acid with an oral MoA. The amendment to the WADPs are as a result of a review conducted by the Department of Health and Ageing.
Administered by: Health
For other related material click here
General Comments: Note an Order of the Federal Court of Australia on 6 December 2012 relating to this instrument, a copy of which is available as supporting material.
Made 05 Nov 2012
Registered 05 Nov 2012
Tabled HR 26 Nov 2012
Tabled Senate 19 Nov 2012
Date of Ceasing 06 Nov 2012
Reason for Ceasing Repealed under Division 1 of Part 5A of the
This Legislative Instrument has been subject to a Motion to Disallow:
Motion DateExpiry DateHouseDetailsProvisionsResolutionResolution DateResolution Time
26-Nov-2012  Senate Partial Sch 1, item 1 Withdrawn 28-Nov-2012 
Skip Navigation Links.

PB 98 of 2012

National Health (Weighted average disclosed price – interim supplementary disclosure cycle) Amendment Determination 2012 (No. 2)

National Health Act 1953

I, FELICTY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this determination under subsection 99ADB(4) of the National Health Act 1953.

Dated  5 November 2012

 

 

 

 

 

 

 

 

 

FELICTY McNEILL

 

First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health and Ageing

 


1              Name of Determination

       (1)     This Determination is the National Health (Weighted average disclosed price – interim supplementary disclosure cycle) Amendment Determination 2012 (No. 2).

       (2)     This Determination may also be cited as PB 98 of 2012.

2              Commencement

                This Determination commences on registration.

 

 

3              Amendments to PB 58 of 2012

Schedule 1 amends the National Health (Weighted average disclosed price – interim supplementary disclosure cycle) Determination 2012 (PB 58 of 2012).


Schedule 1             Amendments

 

 

[1]      Schedule 1

 

             omit:

 

2

Docetaxel

Injection set containing 1 single use vial concentrate for I.V. infusion 80 mg (anhydrous) in 2 mL with solvent

Injection

Taxotere

275.00

295.68

3

Docetaxel

Powder for I.V. infusion 20 mg with solvent

Injection

Docetaxel SUN

68.61

73.77

4

Docetaxel

Powder for I.V. infusion 80 mg with solvent

Injection

Docetaxel SUN

275.00

295.68

5

Docetaxel

Solution concentrate for I.V. infusion 140 mg in 7 mL

Injection

Oncotaxel 140

479.17

515.20

6

Docetaxel

Solution concentrate for I.V. infusion 160 mg in 16 mL

Injection

DBL Docetaxel Concentrated Injection

549.99

591.35

7

Docetaxel

Solution concentrate for I.V. infusion 20 mg in 1 mL

Injection

Oncotaxel 20

68.61

73.77

8

Docetaxel

Solution concentrate for I.V. infusion 20 mg in 1 mL

Injection

Taxotere

68.61

73.77

9

Docetaxel

Solution concentrate for I.V. infusion 20 mg in 2 mL

Injection

DBL Docetaxel Concentrated Injection

68.61

73.77

10

Docetaxel

Solution concentrate for I.V. infusion 20 mg in 2 mL

Injection

Docetaxel Ebewe

68.61

73.77

11

Docetaxel

Solution concentrate for I.V. infusion 20 mg in 2 mL

Injection

Docetaxel Sandoz

68.61

73.77

12

Docetaxel

Solution concentrate for I.V. infusion 80 mg in 4 mL

Injection

Oncotaxel 80

275.00

295.68

13

Docetaxel

Solution concentrate for I.V. infusion 80 mg in 4 mL

Injection

Taxotere

275.00

295.68

14

Docetaxel

Solution concentrate for I.V. infusion 80 mg in 8 mL

Injection

DBL Docetaxel Concentrated Injection

275.00

295.68

15

Docetaxel

Solution concentrate for I.V. infusion 80 mg in 8 mL

Injection

Docetaxel Ebewe

275.00

295.68

16

Docetaxel

Solution concentrate for I.V. infusion 80 mg in 8 mL

Injection

Docetaxel Sandoz

275.00

295.68

 

insert:

 

2

Docetaxel

Injection set containing 1 single use vial concentrate for I.V. infusion 80 mg (anhydrous) in 2 mL with solvent

Injection

Taxotere

267.72

 

3

Docetaxel

Powder for I.V. infusion 20 mg with solvent

Injection

Docetaxel SUN

66.80

 

4

Docetaxel

Powder for I.V. infusion 80 mg with solvent

Injection

Docetaxel SUN

267.72

 

5

Docetaxel

Solution concentrate for I.V. infusion 140 mg in 7 mL

Injection

Oncotaxel 140

466.48

 

6

Docetaxel

Solution concentrate for I.V. infusion 160 mg in 16 mL

Injection

DBL Docetaxel Concentrated Injection

535.44

 

7

Docetaxel

Solution concentrate for I.V. infusion 20 mg in 1 mL

Injection

Oncotaxel 20

66.80

 

8

Docetaxel

Solution concentrate for I.V. infusion 20 mg in 1 mL

Injection

Taxotere

66.80

 

9

Docetaxel

Solution concentrate for I.V. infusion 20 mg in 2 mL

Injection

DBL Docetaxel Concentrated Injection

66.80

 

10

Docetaxel

Solution concentrate for I.V. infusion 20 mg in 2 mL

Injection

Docetaxel Ebewe

66.80

 

11

Docetaxel

Solution concentrate for I.V. infusion 20 mg in 2 mL

Injection

Docetaxel Sandoz

66.80

 

12

Docetaxel

Solution concentrate for I.V. infusion 80 mg in 4 mL

Injection

Oncotaxel 80

267.72

 

13

Docetaxel

Solution concentrate for I.V. infusion 80 mg in 4 mL

Injection

Taxotere

267.72

 

14

Docetaxel

Solution concentrate for I.V. infusion 80 mg in 8 mL

Injection

DBL Docetaxel Concentrated Injection

267.72

 

15

Docetaxel

Solution concentrate for I.V. infusion 80 mg in 8 mL

Injection

Docetaxel Ebewe

267.72

 

16

Docetaxel

Solution concentrate for I.V. infusion 80 mg in 8 mL

Injection

Docetaxel Sandoz

267.72

 

 

[2]      Schedule 1

 

             omit:

 

50

Risedronic Acid

Tablet (enteric coated) containing risedronate sodium 35 mg

Oral

Actonel EC

25.11

27.00

51

Risedronic Acid

Tablet containing risedronate sodium 150 mg

Oral

Actonel Once-a-Month

27.21

29.26

52

Risedronic Acid

Tablet containing risedronate sodium 30 mg

Oral

Actonel

165.89

178.36

53

Risedronic Acid

Tablet containing risedronate sodium 35 mg

Oral

Acris Once-a-Week

25.11

27.00

54

Risedronic Acid

Tablet containing risedronate sodium 35 mg

Oral

APO-Risedronate

25.11

27.00

55

Risedronic Acid

Tablet containing risedronate sodium 35 mg

Oral

Chem mart Risedronate

25.11

27.00

56

Risedronic Acid

Tablet containing risedronate sodium 35 mg

Oral

Risedro once a week

25.11

27.00

57

Risedronic Acid

Tablet containing risedronate sodium 35 mg

Oral

Risedronate Sandoz

25.11

27.00

58

Risedronic Acid

Tablet containing risedronate sodium 35 mg

Oral

Risedronate-GA

25.11

27.00

59

Risedronic Acid

Tablet containing risedronate sodium 35 mg

Oral

Terry White Chemists Risedronate

25.11

27.00

60

Risedronic Acid

Tablet containing risedronate sodium 5 mg

Oral

Actonel

25.11

27.00

 

insert:

 

50

Risedronic Acid

Tablet (enteric coated) containing risedronate sodium 35 mg

Oral

Actonel EC

25.49

 

51

Risedronic Acid

Tablet containing risedronate sodium 150 mg

Oral

Actonel Once-a-Month

27.62

 

52

Risedronic Acid

Tablet containing risedronate sodium 30 mg

Oral

Actonel

168.36

 

53

Risedronic Acid

Tablet containing risedronate sodium 35 mg

Oral

Acris Once-a-Week

25.49

 

54

Risedronic Acid

Tablet containing risedronate sodium 35 mg

Oral

APO-Risedronate

25.49

 

55

Risedronic Acid

Tablet containing risedronate sodium 35 mg

Oral

Chem mart Risedronate

25.49

 

56

Risedronic Acid

Tablet containing risedronate sodium 35 mg

Oral

Risedro once a week

25.49

 

57

Risedronic Acid

Tablet containing risedronate sodium 35 mg

Oral

Risedronate Sandoz

25.49

 

58

Risedronic Acid

Tablet containing risedronate sodium 35 mg

Oral

Risedronate-GA

25.49

 

59

Risedronic Acid

Tablet containing risedronate sodium 35 mg

Oral

Terry White Chemists Risedronate

25.49

 

60

Risedronic Acid

Tablet containing risedronate sodium 5 mg

Oral

Actonel

25.49

 

 

Note

1.       All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.frli.gov.au.

Back to Top Back to Top